FAQ
Questions Before a Project Starts.
Short answers to the questions clients most often ask before a pharmaceutical facility project is scoped. For anything specific to your project, an engineer will reply directly.
Design starts from the product portfolio and dosage forms, whether the scope includes sterile, nonsterile, or hazardous-drug activities, the expected capacity and shift pattern, the site or existing building, available utilities, the target markets and their regulatory framework, and the intended schedule and budget range. A short description is enough to begin; existing studies, layouts, or a project brief help define a more precise scope.
Concept engineering fixes the strategy: zoning, personnel and material flows, area classification, utility concept, and equipment strategy. Basic engineering defines the systems: layouts, process and utility flow diagrams, equipment lists, HVAC zoning, and preliminary sizing. Detailed engineering develops that definition into coordinated drawings, specifications, and data that can be procured and built.
From the first layout. Zoning, personnel and material flows, pressure relationships, and utilities are hard to change once the design is fixed, so GMP requirements should shape the concept rather than be checked after it. They then carry through basic and detailed engineering, procurement, construction, and qualification.
Yes. Upgrade studies, GMP gap assessments, engineering changes, utility improvements, and expansion planning can be scoped around ongoing production, with phasing, temporary arrangements, and requalification planned to limit disruption.
Yes. An upgrade usually starts with a review of the current zoning, pressure cascade, and air handling against the process, followed by a phased design that keeps requalification in view.
It is the combination of treatment, storage, and distribution equipment that produces water of a defined quality and delivers it to each use point. A typical system includes pretreatment, reverse osmosis (RO), often a polishing step such as EDI, a storage tank, and a recirculating distribution loop with sanitization and monitoring. WFI generation and clean steam are added where the process requires them.
Reverse osmosis is usually the main purification step after pretreatment. It removes most dissolved salts, organics, particles, and microorganisms from the feed water. It is typically followed by further polishing, such as EDI or a second RO pass, and its performance depends on pretreatment that protects the membranes.
Purified water (PW) is used in many nonsterile applications and as the feed for further treatment. Water for injection (WFI) is a higher grade with tighter microbial and endotoxin control, used where the product or process requires it, such as parenteral preparations and final rinsing of product-contact parts. The applicable specifications come from the pharmacopeia and regulatory framework of each project, and the grade needed at each use point is confirmed during design.
A pressure cascade keeps air moving in a defined direction between rooms. In most clean areas air moves from cleaner to less clean spaces to protect the product; in containment areas, rooms are held at negative pressure so that air moves inward to protect people and the surroundings. There are no universal values: differential pressures are set per project from room classification, the applicable guidance, and risk, then monitored and verified.
Yes, as an engineering scope. This can cover layouts and containment zoning, negative-pressure regimes, exhaust strategy, the integration of containment primary engineering controls, PPE and access routes, and the hazardous waste route. The scope is defined per project from the drugs, dosage forms, and activities involved.
They are the main qualification stages. Design qualification (DQ) documents that the design meets the user requirements. Installation qualification (IQ) verifies that equipment and systems are installed as specified. Operational qualification (OQ) verifies that they operate as intended across their operating ranges. Performance qualification (PQ) verifies that they perform consistently under actual or representative conditions.
Support can include validation master planning, URS support, design qualification, FAT and SAT support, IQ/OQ/PQ protocol development and execution support, and traceability between requirements and test evidence.
Yes. Commissioning support can include planning, system walkdowns, SAT and start-up support, and punch-list follow-up, with records structured so that qualification can build on them rather than repeat them. The exact scope is agreed per project.
Yes. Equipment procurement support can cover URS and technical specifications, vendor prequalification, technical bid evaluation, vendor document review, and FAT coordination. The division of commercial responsibilities is agreed per project.
Procurement support covers specifications, vendor prequalification, technical bid evaluation, and FAT coordination. Construction support covers site engineering, submittal and shop-drawing review, inspections, and handover support. The exact scope is agreed per project.
Turnkey and integrated project delivery services may be provided according to project scope and contractual model.
Please contact us with the project location and scope, and we will confirm how we can support it.
It is a facility where medications are prepared for specific patients or uses, rather than manufactured in large commercial batches. Depending on the preparations involved, it can include non-sterile compounding rooms, sterile compounding suites, hazardous drug areas and supporting spaces for storage, washing, quality control, packing and waste. From an engineering perspective, the facility is a set of rooms, routes and systems that must work together around each type of preparation.
Sterile compounding prepares medications that must remain free of viable microorganisms, so it typically relies on a controlled sequence of classified rooms, gowning, filtered air, pressure relationships and primary engineering controls. Non-sterile compounding covers preparations such as oral liquids, creams or capsules; it still needs clear separation, cleanable finishes, dust control and dedicated washing, but it does not always require classified cleanrooms. The environment each facility needs is defined per project from the preparations and the applicable requirements.
The facility must protect personnel and the surroundings as well as the preparation. That usually shifts the engineering toward containment: dedicated receiving and unpacking, segregated storage, containment primary engineering controls, rooms held at negative pressure where required, exhaust strategy, PPE donning and doffing, decontamination provisions and a separate waste route. The exact measures depend on the drugs, dosage forms and activities in each project.
Most contamination and containment problems start where routes cross: clean materials meeting used items, people moving between areas of different cleanliness without a defined transition, or waste leaving through a clean corridor. Planning these routes first, from receipt to dispatch and disposal, allows the room layout, airlocks, pass boxes and pressure relationships to support the intended workflow instead of working against it.
Pressure relationships set the direction in which air moves between rooms. Where the priority is protecting the preparation, air generally moves from cleaner to less clean spaces; where the priority is containing a hazardous drug, rooms are typically held negative so that air moves inward. The relationships and the differential values are defined per project from the room functions, risk assessment and applicable requirements, then monitored and verified.
Not necessarily. It depends on the type of preparation, the jurisdiction and the project. Sterile compounding typically involves classified environments, while many non-sterile activities can be carried out in controlled, cleanable rooms without a cleanroom classification. The appropriate environment for each activity is confirmed with the client and the relevant requirements during the early design stages.
HVAC zones follow the activities, not only the floor plan. Rooms are grouped by cleanliness, containment needs, pressure regime, temperature and humidity requirements and operating hours, so that areas with conflicting needs, such as hazardous and non-hazardous compounding or laboratories and preparation rooms, are not served in a way that compromises segregation. Supply, return, exhaust and filtration are then developed for each zone.
Depending on the preparations and equipment, utilities may include pharmaceutical water for preparation and washing, compressed air, clean steam where sterilization equipment requires it, drainage designed to avoid contamination, and power continuity for critical systems. Not every facility needs every utility; the list is defined per use point during design.
CQV stands for commissioning, qualification and validation. Commissioning confirms that systems such as HVAC, monitoring and utilities are installed and working; qualification documents that rooms, equipment and systems meet their defined requirements; and validation shows that the processes perform consistently. ALVEDA supports planning and documentation of this path; the scope and the parties executing each activity are agreed per project.
Yes. An upgrade usually starts with a gap assessment of the current layout, routes, pressure relationships, HVAC, utilities and monitoring against the confirmed requirements, followed by a prioritized engineering response and a phased implementation plan that considers ongoing operation and requalification.
Next step
Planning a pharmaceutical project?
Share the product type, the current stage and the main constraints. We will respond with a proposed scope and next steps.
+20 101 171 1700